ABVC BioPharma, Inc. (ABVC) Financials

ABVC Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2023 14.5 million 6.4 million
Sept. 30, 2023 16.6 million 7.5 million
June 30, 2023 9.3 million 9.7 million
March 31, 2023 10.7 million 9.0 million

ABVC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 -479460 225739
Sept. 30, 2023 -1.4 million 817740
June 30, 2023 -899827 225740
March 31, 2023 -1.5 million 366489

ABVC Net Income

No data available :(

ABVC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 - - 809283
Sept. 30, 2023 568590 - 899817
June 30, 2023 176077 - 999645
March 31, 2023 1.2 million - 1.1 million

ABVC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 7.9 million
Sept. 30, 2023 4.1 million
June 30, 2023 3.3 million
March 31, 2023 3.3 million

ABVC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 - 72185 1.8 million -
Sept. 30, 2023 21201 141310 2.0 million -
June 30, 2023 - 514442 1.6 million -
March 31, 2023 - 334979 1.6 million -

ABVC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 2165 139206
Sept. 30, 2023 15884 29614
June 30, 2023 6109 72981
March 31, 2023 128272 60236

ABVC

Price: $0.87

52 week price:
0.85
3.40

Earnings Per Share: -0.28 USD

P/E Ratio: -5.18

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 67000

Market Capitalization: 14.6 million

Links: